Compare VNCE & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNCE | INO |
|---|---|---|
| Founded | 2002 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.5M | 118.9M |
| IPO Year | 2013 | 1999 |
| Metric | VNCE | INO |
|---|---|---|
| Price | $10.67 | $0.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $15.00 | $3.17 |
| AVG Volume (30 Days) | 326.0K | ★ 3.7M |
| Earning Date | 12-08-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.45 | 54.18 |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $300,007,000.00 | $42,220,086.00 |
| Revenue This Year | $12.72 | $920.26 |
| Revenue Next Year | $17.67 | $7,490.76 |
| P/E Ratio | $16.09 | ★ N/A |
| Revenue Growth | 2.23 | ★ 19.37 |
| 52 Week Low | $1.95 | $0.56 |
| 52 Week High | $13.78 | $2.72 |
| Indicator | VNCE | INO |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 27.34 |
| Support Level | $9.82 | $0.56 |
| Resistance Level | $13.41 | $1.23 |
| Average True Range (ATR) | 1.05 | 0.14 |
| MACD | -0.33 | -0.03 |
| Stochastic Oscillator | 10.64 | 0.84 |
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale and Vince Direct-to-consumer. It operates its e-commerce business through its website. Maximum of its revenue generated from Vince Wholesale segment.
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.